Profile of:

Annelies Boonen


Annelies Boonen is professor of rheumatology and head of the Department of Rheumatology at Maastricht University Medical Centre. Her interest is in socio-economic aspects of inflammatory rheumatic diseases. On the one hand, insight into cost-effectiveness of making diagnoses and treating patients are important to keep healthcare affordable. Such models are often complex and their quality highly depends on clinical experience with the disease and its management combined with knowledge of data from epidemiological and clinical studies. Therefore, rheumatologist are in the best position to lead the development of such models. On the other hand, country-level and individual level socio-economic determinants should receive attention when we aim to uncover the socio-economic gap in health outcomes. Annelies Boonen advocates that health-economic evaluations of innovations and adaptation of care to patients' specific socio-economic background and health literacy skills will contribute to sustainability but also affordability and equity of healthcare. As in all clinical studies, choosing the most valid outcome is of key importance to provide valid results.

Full name: Annelies Boonen

Current country: Netherlands

Membership level: Full

Type of membership: Member

Number of publications: 50

Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry (2022)
https://pubmed.ncbi.nlm.nih.gov/36109082/

Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals (2022)
https://pubmed.ncbi.nlm.nih.gov/35438147/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/34387300/

Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34470791/

Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT (2022)
https://pubmed.ncbi.nlm.nih.gov/36099046/

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? (2022)
https://pubmed.ncbi.nlm.nih.gov/36205588/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35654458/

Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35649557/

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35361692/

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35351808/

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35260387/

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/34320627/

Treat-to-target in axial spondyloarthritis: an observational study in daily practice (2022)
https://pubmed.ncbi.nlm.nih.gov/34175950/

Do tender joints in active psoriatic arthritis reflect inflammation assessed by ultrasound and magnetic resonance imaging? (2022)
https://pubmed.ncbi.nlm.nih.gov/33895799/

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial (2022)
https://pubmed.ncbi.nlm.nih.gov/33044756/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey (2021)
https://pubmed.ncbi.nlm.nih.gov/34334361/

Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/34172511/

Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34153894/

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33958325/

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33589554/

Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals? (2021)
https://pubmed.ncbi.nlm.nih.gov/33026713/

Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies (2021)
https://pubmed.ncbi.nlm.nih.gov/32669450/

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT) (2020)
https://pubmed.ncbi.nlm.nih.gov/32993799/

(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32340709/

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands (2020)
https://pubmed.ncbi.nlm.nih.gov/32318970/

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study (2020)
https://pubmed.ncbi.nlm.nih.gov/31665462/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study (2019)
https://pubmed.ncbi.nlm.nih.gov/31639012/

Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI (2019)
https://pubmed.ncbi.nlm.nih.gov/31245046/

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net) (2019)
https://pubmed.ncbi.nlm.nih.gov/31168405/

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA) (2019)
https://pubmed.ncbi.nlm.nih.gov/30674477/

International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group (2019)
https://pubmed.ncbi.nlm.nih.gov/30358135/

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life (2018)
https://pubmed.ncbi.nlm.nih.gov/30487997/

Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study (2018)
https://pubmed.ncbi.nlm.nih.gov/30018801/

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study (2018)
https://pubmed.ncbi.nlm.nih.gov/29860232/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29858176/

Are globals for health, well-being and quality of life interchangeable? A mixed methods study in ankylosing spondylitis patients and controls (2018)
https://pubmed.ncbi.nlm.nih.gov/29788458/

Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons (2018)
https://pubmed.ncbi.nlm.nih.gov/29465359/

Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work (2018)
https://pubmed.ncbi.nlm.nih.gov/29373701/

Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls (2018)
https://pubmed.ncbi.nlm.nih.gov/28622457/

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach (2018)
https://pubmed.ncbi.nlm.nih.gov/28575536/

Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain (2017)
https://pubmed.ncbi.nlm.nih.gov/28623950/

OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients? (2017)
https://pubmed.ncbi.nlm.nih.gov/28298567/

Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients (2017)
https://pubmed.ncbi.nlm.nih.gov/27980007/

Social Role Participation in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparison With Population Controls (2016)
https://pubmed.ncbi.nlm.nih.gov/27059161/

Electronic assessment of disease activity and functioning in patients with axial spondyloarthritis: challenges and unmet needs (2016)
https://pubmed.ncbi.nlm.nih.gov/27762203/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/